Spots Global Cancer Trial Database for Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Official Title: Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Study ID: NCT00681369
Conditions
Interventions
Study Description
Brief Summary: the purpose of this study is to describe the way Faslodex is used in France, in patients suffering from initial breast cancer, that is to evaluate Faslodex treatment duration and to determine patients profile
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Alain FLINOIS
Affiliation: TNS Healthcare - France138, avenue Marx Dormoy92120 Montrouge
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
